"NVS" の関連情報検索結果

Novartis AG (NVS) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance



Novartis AG (NVS) Hits Fresh High: Is There Still Room to Run?  Yahoo Finance

Phase III Setback: Novartis Cosentyx Falls Short in Giant Cell Arteritis Trial Results - Stock Titan



Phase III Setback: Novartis Cosentyx Falls Short in Giant Cell Arteritis Trial Results  Stock Titan

Novartis (NVS) provides update on Phase III GCAptAIN study of Cosentyx in giant cell arteritis - ...



Novartis (NVS) provides update on Phase III GCAptAIN study of Cosentyx in giant cell arteritis  StreetInsider

PFE, NVS, and JNJ: The Shining Stars of the Sluggish Healthcare Sector - TipRanks



PFE, NVS, and JNJ: The Shining Stars of the Sluggish Healthcare Sector  TipRanks

(NVS) Technical Data - news.stocktradersdaily.com



(NVS) Technical Data  news.stocktradersdaily.com

Novartis (NVS): Cosentyx Falls Short in Key Phase 3 Trial for GCA - GuruFocus



Novartis (NVS): Cosentyx Falls Short in Key Phase 3 Trial for GCA  GuruFocus

Novartis fails in Phase 3 trial for Cosentyx (NVS:NYSE) - Seeking Alpha



Novartis fails in Phase 3 trial for Cosentyx (NVS:NYSE)  Seeking Alpha

Novartis' Cosentyx Fails Late-Stage Giant Cell Arteritis Trial - Benzinga



Novartis' Cosentyx Fails Late-Stage Giant Cell Arteritis Trial  Benzinga

Novartis (NVS) Acquires Regulus Therapeutics for $1.7 Billion - MSN



Novartis (NVS) Acquires Regulus Therapeutics for $1.7 Billion  MSN

Novartis' Cosentyx Misses Primary Goal in Arteritis Phase III Study - TradingView



Novartis' Cosentyx Misses Primary Goal in Arteritis Phase III Study  TradingView

NVS-02: Navigation signals from transfer orbit - GPS World



NVS-02: Navigation signals from transfer orbit  GPS World

Deutsche Bank Remains a Buy on Novartis (NVS) With a CHF115 PT - Insider Monkey



Deutsche Bank Remains a Buy on Novartis (NVS) With a CHF115 PT  Insider Monkey

Novartis (NVS) Reports Positive Outcomes in Phase IIIB Fabhalta Study | NVS Stock News - GuruFocus



Novartis (NVS) Reports Positive Outcomes in Phase IIIB Fabhalta Study | NVS Stock News  GuruFocus

Novartis AG (NVS): A Bull Case Theory - MSN



Novartis AG (NVS): A Bull Case Theory  MSN

Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance



Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue?  Yahoo Finance

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term - Yahoo Finance



Why Novartis (NVS) is a Top Momentum Stock for the Long-Term  Yahoo Finance

Should Value Investors Buy Novartis (NVS) Stock? - Yahoo Finance



Should Value Investors Buy Novartis (NVS) Stock?  Yahoo Finance

Here's Why Novartis (NVS) is a Strong Value Stock - Nasdaq



Here's Why Novartis (NVS) is a Strong Value Stock  Nasdaq

Here's Why Novartis (NVS) is a Strong Value Stock - Yahoo Finance



Here's Why Novartis (NVS) is a Strong Value Stock  Yahoo Finance

Novartis: A SWAN Worth Owning (NYSE:NVS) - Seeking Alpha



Novartis: A SWAN Worth Owning (NYSE:NVS)  Seeking Alpha

Novartis AG (NVS) Q1 2025 Earnings Call Highlights: Impressive Growth and Strategic Advancements ...



Novartis AG (NVS) Q1 2025 Earnings Call Highlights: Impressive Growth and Strategic Advancements  Yahoo Finance

Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke - TipRanks



Novartis (NVS) Unleashes $23BN Strategic Investment Masterstroke  TipRanks

Why Novartis (NVS) is a Great Dividend Stock Right Now - Yahoo Finance



Why Novartis (NVS) is a Great Dividend Stock Right Now  Yahoo Finance

What Makes Novartis AG (NVS) a Differentiated Business? - Yahoo Finance



What Makes Novartis AG (NVS) a Differentiated Business?  Yahoo Finance

Here's Why Novartis (NVS) is a Strong Momentum Stock - Yahoo Finance



Here's Why Novartis (NVS) is a Strong Momentum Stock  Yahoo Finance

Novartis (NVS) Advances in Acquisition with Key Regulatory Appro - GuruFocus



Novartis (NVS) Advances in Acquisition with Key Regulatory Appro  GuruFocus

Why Novartis (NVS) is a Top Dividend Stock for Your Portfolio - Yahoo Finance



Why Novartis (NVS) is a Top Dividend Stock for Your Portfolio  Yahoo Finance

India Strengthens Regional Navigation with Advanced NVS-02 Satellite - Forecast International



India Strengthens Regional Navigation with Advanced NVS-02 Satellite  Forecast International

Berenberg Bank Maintains a Hold Rating on Novartis (NVS) - Insider Monkey



Berenberg Bank Maintains a Hold Rating on Novartis (NVS)  Insider Monkey

Novartis (NVS) Concludes Acquisition Offer for Regulus Therapeutics | NVS Stock News - GuruFocus



Novartis (NVS) Concludes Acquisition Offer for Regulus Therapeutics | NVS Stock News  GuruFocus

Here's Why Novartis (NVS) is a Strong Momentum Stock - Nasdaq



Here's Why Novartis (NVS) is a Strong Momentum Stock  Nasdaq

Novartis (NVS) Partners with ProFound for Cardiovascular Drug De - GuruFocus



Novartis (NVS) Partners with ProFound for Cardiovascular Drug De  GuruFocus

Novartis AG (NVS): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts - Yahoo Fin...



Novartis AG (NVS): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts  Yahoo Finance

Novartis AG (NVS): Among the Best Undervalued Stocks to Invest In Now - Yahoo Finance



Novartis AG (NVS): Among the Best Undervalued Stocks to Invest In Now  Yahoo Finance

Why Novartis (NVS) is a Top Momentum Stock for the Long-Term - Nasdaq



Why Novartis (NVS) is a Top Momentum Stock for the Long-Term  Nasdaq

NVS August 15th Options Begin Trading - Nasdaq



NVS August 15th Options Begin Trading  Nasdaq

Compared to Estimates, Novartis (NVS) Q1 Earnings: A Look at Key Metrics - Nasdaq



Compared to Estimates, Novartis (NVS) Q1 Earnings: A Look at Key Metrics  Nasdaq

Novartis After Sandoz: The Business Without Generics (NYSE:NVS) - Seeking Alpha



Novartis After Sandoz: The Business Without Generics (NYSE:NVS)  Seeking Alpha

Novartis (NVS) Completes Acquisition of Regulus Therapeutics | NVS Stock News - GuruFocus



Novartis (NVS) Completes Acquisition of Regulus Therapeutics | NVS Stock News  GuruFocus

Novartis (NVS) is a Great Momentum Stock: Should You Buy? - Yahoo Finance



Novartis (NVS) is a Great Momentum Stock: Should You Buy?  Yahoo Finance

Novartis (NVS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance



Novartis (NVS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates  Yahoo Finance

NVS: 3 Gene Therapy Stocks With Game-Changing Potential - StockNews



NVS: 3 Gene Therapy Stocks With Game-Changing Potential  StockNews

India’s first launch of 2025 sends NVS-02 navigation satellite into orbit - SpaceNews



India’s first launch of 2025 sends NVS-02 navigation satellite into orbit  SpaceNews

Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeut...



Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate  PR Newswire

Novartis AG (NVS): Among the Best Global Stocks to Buy According to Hedge Funds - Yahoo Finance



Novartis AG (NVS): Among the Best Global Stocks to Buy According to Hedge Funds  Yahoo Finance

Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains? - Nasdaq



Novartis (NVS) Surges 4.0%: Is This an Indication of Further Gains?  Nasdaq

Novartis (NVS) Could Be a Great Choice - Yahoo Finance



Novartis (NVS) Could Be a Great Choice  Yahoo Finance

Novartis (NVS) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance



Novartis (NVS) Upgraded to Buy: What Does It Mean for the Stock?  Yahoo Finance

Why Novartis AG (NVS) Is a Pharma Titan Built for the Next Decade - AInvest



Why Novartis AG (NVS) Is a Pharma Titan Built for the Next Decade  AInvest

NVS Plans to Invest $23B in US Manufacturing Sites Amid Tariff Threat - TradingView



NVS Plans to Invest $23B in US Manufacturing Sites Amid Tariff Threat  TradingView

NVS Named Top 10 SAFE International Dividend Stock - Nasdaq



NVS Named Top 10 SAFE International Dividend Stock  Nasdaq

A $100 Million Problem? ISRO’s NVS-02 Navigation Satellite Stuck in Orbit - Orbital Today



A $100 Million Problem? ISRO’s NVS-02 Navigation Satellite Stuck in Orbit  Orbital Today

Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs - Yahoo Finance



Pharma Stock Roundup: NVS, ABBV M&A Deals, FDA Nod to RHHBY, PFE Drugs  Yahoo Finance

FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers - Benzinga



FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers  Benzinga

Should Value Investors Buy Novartis (NVS) Stock? - Nasdaq



Should Value Investors Buy Novartis (NVS) Stock?  Nasdaq

NVS - Novartis Latest Stock News & Market Updates - Stock Titan



NVS - Novartis Latest Stock News & Market Updates  Stock Titan

Novartis (NVS) Could Be a Great Choice - Nasdaq



Novartis (NVS) Could Be a Great Choice  Nasdaq

Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure - Yahoo Finance



Pharma Stock Roundup: FDA Nod to SNY, AZN & NVS, JNJ Talc Suits Failure  Yahoo Finance

Enhanced scavenger-free photocatalysis-self-Fenton degradation performance over B-doped NVs modif...



Enhanced scavenger-free photocatalysis-self-Fenton degradation performance over B-doped NVs modified g-C  ScienceDirect.com

Why Novartis (NVS) is a Top Value Stock for the Long-Term - Nasdaq



Why Novartis (NVS) is a Top Value Stock for the Long-Term  Nasdaq

Novartis (NVS) Unveils $23B U.S. Expansion Plan To Boost Domesti - GuruFocus



Novartis (NVS) Unveils $23B U.S. Expansion Plan To Boost Domesti  GuruFocus

Regulus Therapeutics (RGLS) to be Acquired by Novartis (NVS) for $7 Per Share - StreetInsider



Regulus Therapeutics (RGLS) to be Acquired by Novartis (NVS) for $7 Per Share  StreetInsider

Final Trade: NVS, XLU, GM - CNBC



Final Trade: NVS, XLU, GM  CNBC

(NVS) Investment Analysis - news.stocktradersdaily.com



(NVS) Investment Analysis  news.stocktradersdaily.com

Breakthrough: Novartis Scores Historic FDA Approval for Rare Kidney Disease Treatment - Stock Titan



Breakthrough: Novartis Scores Historic FDA Approval for Rare Kidney Disease Treatment  Stock Titan

Final Trade: NVS, XLU and SMMT - CNBC



Final Trade: NVS, XLU and SMMT  CNBC

Novartis: Explaining YE24 Loss Of Momentum, Outlining Prospects For 2025 (NYSE:NVS) - Seeking Alpha



Novartis: Explaining YE24 Loss Of Momentum, Outlining Prospects For 2025 (NYSE:NVS)  Seeking Alpha

As Novartis builds momentum with new drug launches, CEO says he's 'comfortable' navigating US tar...



As Novartis builds momentum with new drug launches, CEO says he's 'comfortable' navigating US tariffs  Fierce Pharma

(NVS) Proactive Strategies - news.stocktradersdaily.com



(NVS) Proactive Strategies  news.stocktradersdaily.com

Indian Research IRNSS-1K (NVS-02) launch Tuesday - news.satnews.com



Indian Research IRNSS-1K (NVS-02) launch Tuesday  news.satnews.com

NVS vs. LLY: Which Stock Should Value Investors Buy Now? - Yahoo Finance



NVS vs. LLY: Which Stock Should Value Investors Buy Now?  Yahoo Finance

Why Novartis (NVS) is a Great Dividend Stock Right Now - Nasdaq



Why Novartis (NVS) is a Great Dividend Stock Right Now  Nasdaq

NVS Plans to Invest $23B in US Manufacturing Sites Amid Tariff Threat - Zacks Investment Research



NVS Plans to Invest $23B in US Manufacturing Sites Amid Tariff Threat  Zacks Investment Research

Novartis AG (NYSE:NVS) Q1 2025 Earnings Call Transcript - Insider Monkey



Novartis AG (NYSE:NVS) Q1 2025 Earnings Call Transcript  Insider Monkey

Novartis (NVS) Stock: Q125 Earnings Beat Boosts Confidence in Oncology and Cardio Drugs - CoinCen...



Novartis (NVS) Stock: Q125 Earnings Beat Boosts Confidence in Oncology and Cardio Drugs  CoinCentral

Indian navigation satellite stranded in transfer orbit after valve malfunction - GPS World



Indian navigation satellite stranded in transfer orbit after valve malfunction  GPS World

Novartis (NVS) Agrees to Acquire Regulus at a Premium Price | NV - GuruFocus



Novartis (NVS) Agrees to Acquire Regulus at a Premium Price | NV  GuruFocus

Ratio Therapeutics Lands $745M Cancer Drug Development Deal with Novartis - Stock Titan



Ratio Therapeutics Lands $745M Cancer Drug Development Deal with Novartis  Stock Titan

Novartis is eyeing $23B investment in U.S.(NVS:NYSE) - Seeking Alpha



Novartis is eyeing $23B investment in U.S.(NVS:NYSE)  Seeking Alpha

Novartis (NVS) Boosts 2025 Outlook with Promising Growth Forecast | NVS Stock News - GuruFocus



Novartis (NVS) Boosts 2025 Outlook with Promising Growth Forecast | NVS Stock News  GuruFocus

Novartis (NVS) Surges on Strong Q4 Earnings and Robust Drug Sales - GuruFocus



Novartis (NVS) Surges on Strong Q4 Earnings and Robust Drug Sales  GuruFocus

ISRO Faces Setback As Its NVS-02 Satellite Thrusters Fail To Ignite In Space - Mashable India



ISRO Faces Setback As Its NVS-02 Satellite Thrusters Fail To Ignite In Space  Mashable India

NV's electric vehicle industry changing under President Trump - Public News Service



NV's electric vehicle industry changing under President Trump  Public News Service

Novartis AG (NVS) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Outlook ......



Novartis AG (NVS) Q4 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Outlook ...  Yahoo Finance

Incyte (INCY) and Novartis (NVS) entered into settlement agreement - StreetInsider



Incyte (INCY) and Novartis (NVS) entered into settlement agreement  StreetInsider

ISRO’s orbit raising operations for NVS-02 satellite disrupted by valve malfunction - The Hindu



ISRO’s orbit raising operations for NVS-02 satellite disrupted by valve malfunction  The Hindu

Novartis (NVS) Reports Positive Interim Results in Prostate Canc - GuruFocus



Novartis (NVS) Reports Positive Interim Results in Prostate Canc  GuruFocus

Novartis (NVS) Reports Positive Interim Results in Prostate Cancer Trial | NVS Stock News - GuruF...



Novartis (NVS) Reports Positive Interim Results in Prostate Cancer Trial | NVS Stock News  GuruFocus

Glitch-hit NVS-02 can provide services only for 2-3 hours per day - Times of India



Glitch-hit NVS-02 can provide services only for 2-3 hours per day  Times of India

Novartis (NVS) To Acquire Regulus Therapeutics in $0.8 Billion D - GuruFocus



Novartis (NVS) To Acquire Regulus Therapeutics in $0.8 Billion D  GuruFocus

(A) Uptake of tomato fruit-derived nanovesicles (NVs) by MDCK cells... - researchgate.net



(A) Uptake of tomato fruit-derived nanovesicles (NVs) by MDCK cells...  researchgate.net

Ionis stock slips as Novartis delays heart drug trial (NVS) - Seeking Alpha



Ionis stock slips as Novartis delays heart drug trial (NVS)  Seeking Alpha

I heterojunction for full-spectrum catalytic organic pollutants mineralization and NO deep oxidat...



I heterojunction for full-spectrum catalytic organic pollutants mineralization and NO deep oxidation  ScienceDirect.com

Novartis: 2025 Guidance Raised To Top End Of Prior Range - Buy Confirmed (NYSE:NVS) - Seeking Alpha



Novartis: 2025 Guidance Raised To Top End Of Prior Range - Buy Confirmed (NYSE:NVS)  Seeking Alpha

Novartis (NVS) May 110 straddle priced into quarter results - StreetInsider



Novartis (NVS) May 110 straddle priced into quarter results  StreetInsider

DFIV, SHEL, HSBC, NVS: Large Inflows Detected at ETF - Nasdaq



DFIV, SHEL, HSBC, NVS: Large Inflows Detected at ETF  Nasdaq

Top Stock Reports for Mastercard, Procter & Gamble & Novartis - Yahoo Finance



Top Stock Reports for Mastercard, Procter & Gamble & Novartis  Yahoo Finance

India’s New Navigation Satellite Is Stranded in the Wrong Orbit After Thruster Glitch - Gizmodo



India’s New Navigation Satellite Is Stranded in the Wrong Orbit After Thruster Glitch  Gizmodo

Down -9.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Novartis (NVS) - Nasdaq



Down -9.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Novartis (NVS)  Nasdaq

Proposed EPA water rule could affect NV's water quality - Public News Service



Proposed EPA water rule could affect NV's water quality  Public News Service